TABLE 2.
Clinical information of six mecC methicillin-resistant Staphylococcus aureus isolates
| Characteristic | Isolate 4402/2009 | Isolate 5127/2010 | Isolate 5590/2012 | Isolate 5625/2012 | Isolate 5676/2012 | Isolate 5752/2013 |
|---|---|---|---|---|---|---|
| Patient age/sex | 89/female | 54/female | 7/female | 72/female | 83/male | 70/male |
| Site of isolation | Blood culture | Multisite screen | Wound swab (outer ear) | Wound swab (leg ulcer) | Nose screen | Blood culture |
| Underlying disease | Myelodysplastic syndrome, sepsis | Diabetes, Eczema | Otitis externa | Ulcus cruris | Stroke | Peripheral arterial occlusion disease, infected leg ulcer |
| Therapy | Unknown | Octenidine/mupirocin | Topical ofloxacin | Topical silver-sulfa-diazine/povidone-iodine | Mupirocin | Clindamycin iv |
| Outcome | Recovered | Eradication | Recovered | Improvement | Eradication | Recovered |
| Risk factors | Unknown | Unknown | Pet rabbit (not screened) | Unknown | Unknown | Unknown |
| Geographic location | Upper Austria | Vienna | Vorarlberg | Vorarlberg | Salzburg | Upper Austria |
No contact could be established between patients.